Mankind Pharma Ltd. share price target

Name: Latest research reports of Mankind Pharma Ltd. authored by HDFC Securities and published by - Trendlyne research reports.
Item: Mankind Pharma Ltd.
Rating: 3
Author: HDFC Securities

Mankind Pharma Ltd. has an average share price target of 2840.50. The consensus estimate represents an upside of 12.10% from the last price of 2534. View 5 reports from 2 analysts offering long-term price targets for Mankind Pharma Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
24 Sep 2025	Mankind Pharma	Consensus Share Price Target	2534.00	2799.65	-	10.48	buy	pdf Detailed Estimates
20 Apr 2023	Mankind Pharma	HDFC Securities	2534.00				IPO Note	pdf post cache	Broker Report IPO Note - Mankind Pharma Limited 20042023 HDFC Securities Issue Snapshot: Issue Open: Apr 25 Apr 27, 2023 Price Band: Rs. 1026 1080 *Issue Size: 4326.36 cr (Entirely Offer for Sale of 40,058,844 eq sh) Reservation for: QIB upto 50% eq sh Non-Institutional atleast 15% eq sh ((including 1/3rd for applications between Rs.2 lakhs to Rs.10 lakhs)) Retail atleast 35% eq sh Face Value: Rs 1 Book value: Rs 178.38 (December 31, 2022) Bid size: - 13 equity shares and in multiples thereof 100% Book built Issue IPO Note - Mankind Pharma Limited pdf Copy Link Share on Share on Share on Share on Alert
20 Apr 2023	Mankind Pharma	Centrum Broking	2534.00				IPO Subscribe	pdf post cache	Broker Report Domestic leader gears up for listing Centrum Broking Mankind is a well?known player in the domestic pharma market (with 97.6% of sales), and is 4th largest in terms of sales and 3rd largest in terms of sales volume as on Dec’22 MAT. About 36 brands in the Pharma business, which has sales over Rs500mn, with strong brand positioning. In the consumer segment, it has leading brands i.e Manforce, Prega News, Unwanted?72, which are having significant market share in their respective categories. pdf Copy Link Share on Share on Share on Share on Alert

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Mankind Pharma Ltd. share price target

Mankind Pharma Ltd. has an average share price target of 2840.50. The consensus estimate represents an upside of 12.10% from the last price of 2534. View 5 reports from 2 analysts offering long-term price targets for Mankind Pharma Ltd..

IPO Note - Mankind Pharma Limited 20042023

Domestic leader gears up for listing

Advisor Screeners